Bangkok Dusit Medical Services Public Company Limited announced audited consolidated earnings results for the fourth quarter and consolidated and separate earnings results for the year ended December 31, 2017. For the quarter, the company reported consolidated operating income of THB 18,734 million against THB 17,666 million a year ago, an increase of 6%. The growth was attributable to an increase in the revenues from hospital operations of 7% year-on-year from both Thai and International patients and from both Bangkok & vicinity and upcountry hospitals. EBITDA was THB 3,898 million against THB 3,665 million a year ago, increased by 6%. Net profit was THB 2,035 million or THB 0.13 per share against THB 1,977 million or THB 0.13 per share a year ago, increased by 3%. EBIT was THB 2,898 million against THB 2,729 million a year ago, increased by 6%. However, due to an increase in finance expenses, core profit were THB 8,021 million, slightly decreased by 2% year-on-year. For the year, on consolidated basis, the company reported total revenues of THB 75,719,470,561 against THB 69,126,213,681 a year ago. Profit before share of income from investments in associates, finance cost and income tax expense was THB 13,256,382,280 against THB 10,205,214,749 a year ago. Profit before income tax expense was THB 13,138,242,322 against THB 10,694,164,866 a year ago. Profit attributable to equity holders of the company was THB 10,215,739,620 or THB 0.66 per basic share against THB 8,386,477,660 or THB 0.54 per basic share a year ago. Net cash flow provided by operating activities was THB 10,933,348,718 against THB 12,446,638,465 a year ago. Cash paid for purchase of property, premises and equipment was THB 15,303,721,720 against THB 8,506,442,347 a year ago. Operating income was THB 72,772 million against THB 68,844 million a year ago, an increase of 6%. The growth was attributable to an increase in the revenues from hospital operations of 6% year-on-year from both Thai and International patients and from both Bangkok & vicinity and upcountry hospitals. The growth was mainly driven by an increase in price intensity. EBITDA was THB 15,477 million against THB 14,726 million a year ago, increased by 5%. EBIT was THB 11,794 million against THB 11,367 million a year ago, increased by 4%. Core profit was THB 8,021 million or THB 0.52 per share against THB 8,220 million or THB 0.53 per share a year ago, decreased by 2%. Return on asset was 8.9% against 8.0% a year ago. Return on equity was 17.2% against 15.5% a year ago. For the year, on separate basis, the company reported total revenues of THB 21,923,917,842 against THB 20,496,275,067 a year ago. Profit before share of income from investments in associates, finance cost and income tax expense was THB 9,614,689,900 against THB 8,257,657,380 a year ago. Profit before income tax expense was THB 7,995,438,977 against THB 7,294,181,825 a year ago. Profit attributable to equity holders of the company was THB 7,051,518,695 or THB 0.46 per basic share against THB 6,935,437,788 or THB 0.45 per basic share a year ago. Net cash flow provided by operating activities was THB 1,885,083,322 against THB 2,617,967,540 a year ago. Cash paid for purchase of property, premises and equipment was THB 1,289,607,894 against THB 2,881,608,544 a year ago.